SLShuxuan Lyu

Shuxuan Lyu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuxuan Lyu has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Brain NaV1.5 fine-tunes neuronal excitability to facilitate female-directed social behavior in male mice

    by Wei Ke, Heyuan Zhang, Liang Li, Yujie Xiao, Shuxuan Lyu, Quansheng He, Xiaoxue Zhang, Luping Yin, Yilin Tai, Yousheng Shu

  • Open Access

    Spindle neurons in human cortex possess distinctive firing properties and transcriptomic signatures

    by Wei Ke, Shuxuan Lyu, Mengmeng Jin, Shaoqing Jiao, Liang Li, Heyuan Zhang, Kexin Ling, Cuiping Tian, Yiquan Song, Liu Chen, et al.

    Spindle neurons (SPNs), also known as von Economo neurons (VENs), are predominantly found in large-brained species including humans. SPNs in human neocortex are implicated in cognitive functions and affected in various brain disorders. Despite their unique morphology, whether SPNs possess distinctive electrophysiological properties and transcriptomic identities remains unclear. Here, we performed whole-cell patch clamp recording (134 cells) together with RNA-sequencing (patch-seq, 124 cells) on visually identified SPNs and pyramidal cells (PCs) in human cortical slices. Compared with putative extratelencephalic-projecting PCs, SPNs possess less complex proximal apical dendrites and emanate axons from the basal dendritic trunk. Additionally, they exhibit heightened excitability and characteristic firing properties, including robust bursting and persistent firing pattern. Patch-seq analysis revealed transcriptomic heterogeneity within SPNs, and identified their fingerprint genes. Collectively, our results indicate that SPNs form a molecularly and functionally distinctive neuronal population, which may serve as a specialized neural substrate for human cortical processing.


  • Tetrodotoxin-resistant NaV1.5 channels regulate excitability of lateral septum neurons and emotion behaviors of chronically stressed mice

    by Junlong Li, Yujie Xiao, Shuxuan Lyu, Kun Wang, Heyuan Zhang, Yuxiang Zheng, Xiaoxue Zhang, Hongkun Yang, Yousheng Shu

    Lateral septum (LS) plays crucial roles in regulating various emotional behaviors. The molecular mechanism governing the excitability of LS neuron (LSN) remains unclear. Using single-nucleus RNA sequencing (snRNA-seq) and immunostaining, we detected high expression levels of Scn5a, the cardiac TTX-resistant voltage-gated Na+ channel (NaV) subtype across many transcriptomic LSN types, and accumulation of its channel protein NaV1.5 at the axon initial segment. Activation of NaV1.5 alone is sufficient to generate action potentials, particularly from a hyperpolarized membrane potential. Knocking out NaV1.5 from LSNs reduces spiking activity and decreases anxiety and depression levels in chronically stressed mice, but not in unstressed ones. Importantly, acute treatment with the antiarrhythmic agent flecainide can diminish the TTX-resistant currents and alleviate the anxiety- and depression-like behaviors of stressed mice. Together, our results reveal a critical role of NaV1.5 channels in governing LSN excitability and identify a potential drug target for a rapid control of emotional disorders.

  • Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson’s disease

    by Kun Cheng Liu, Yuan Guo, Jin Zhang, Li Chen, Yi Wei Liu, Shu Xuan Lv, Wen Xie, Hui Sheng Wang, Yu Ming Zhang, Li Zhang

    Objectives: This study aimed to investigate the effect of serotonin6 (5-HT6) receptors in the dorsal hippocampus (dHip) on the regulation of Parkinson’s disease (PD)-associated anxiety. Methods: We examined whether intra-dHip injection of both 5-HT6 receptor agonist and antagonist was involved in the regulation of anxiety-like behaviors in sham-operated rats and rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle by the open-field and elevated plus maze (EPM) tests. Four weeks after injection of 6-OHDA, the concentrations of dopamine (DA), noradrenaline (NA) and 5-hydroxytryptamine (5-HT) in relative related brain regions were measured by reverse-phase high-performance liquid chromatography. Results: In sham-operated rats, intra-dHip injection of both 5-HT6 receptor agonist WAY208466 (3 and 6 µg/rat) and antagonist SB258585 (4 µg/rat) increased the percentage of time spent in the center area in the open-field test and percentages of open arm entries and open arm time in EPM test, indicating that induced anxiolytic effects. In the lesioned rats, WAY208466 (1.5, 3 and 6 µg/rat) produced anxiolytic responses, whereas SB258585 (2 and 4 µg/rat) produced anxiogenic effects. Neurochemical results showed that intra-dHip injection of WAY208466 (6 µg/rat) decreased NA level in the amygdala, and SB258585 (4 µg/rat) increased DA levels in the dHip and vHip in sham-operated rats, whereas WAY208466 increased DA levels in the dHip, vHip, and amygdala in the lesioned rats. Discussion: dHip 5-HT6 receptors are involved in the regulation of anxiety-like behaviors, which may be mediated through different neurochemical mechanisms, and the dHip is an important site involved in these effects. Abbreviation: PD: Parkinson’s disease;6-OHDA: 6-hydroxydopamine; dHip: dorsal hippocampus; vHip: ventral hippocampus; 5-HT: serotonin; MFB: medial forebrain bundle; DA: dopamine; NA: noradrenaline; EPM: elevated plus-maze; GABA: gamma-aminobutyric acid; BLA: basolateral amygdala


  • Enhanced AMPA receptor-mediated excitatory transmission in the rodent rostromedial tegmental nucleus following lesion of the nigrostriatal pathway

    by Yongli Chang, Chengxue Du, Lingna Han, Shuxuan Lv, Jin Zhang, Guanyun Bian, Guoyi Tang, Yiwei Liu, Tao Chen, Jian Liu


  • Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats

    by Cheng Xue Du, Yuan Guo, Qiao Jun Zhang, Jin Zhang, Shu Xuan Lv, Jian Liu

    Objective: At present, little is known about the role of serotonin7 (5-HT7) receptor in anxiety, particularly in Parkinson’s disease-related anxiety. Here, we tested whether 5-HT7 receptors in the prelimbic (PrL) cortex are involved in the regulation of anxiety-like behaviors in sham-operated rats and rats with unilateral 6-hydroxydopamine lesions of the medial forebrain bundle (MFB). Methods: The open field and elevated plus maze (EPM) tests were performed to study the influence of MFB lesion and intra-PrL injection of 5-HT7 agonist AS19 (0.5, 1 or 2 μg/rat) and antagonist SB269970 (1.5, 3 or 6 μg/rat) on anxiety-like behaviors. Additionally, changes in monoamine levels in limbic and limbic-related brain regions were observed after intra-PrL injection of AS19 (2 μg/rat) and SB269970 (6 μg/rat). Results: The MFB lesion induced anxiety-like behaviors compared to sham-operated rats. Intra-PrL injection of AS19 showed anxiolytic effects by the open field and EPM tests in two groups of rats, and administration of SB269970 showed anxiogenic responses. However, the doses producing these effects in the lesioned rats were higher than those in sham-operated rats. Neurochemical results showed that intra-PrL injection of AS19 increased dopamine, 5-HT and noradrenaline (NA) levels in the medial prefrontal cortex, ventral hippocampus and amygdala in two groups of rats, whereas SB269970 decreased 5-HT and NA levels in these brain regions. Discussion: 5-HT7 receptors in the PrL are involved in the regulation of anxiety-like behaviors, which is attributable to changes in dopamine, 5-HT and NA levels in the limbic and limbic-related brain regions after activation and blockade of 5-HT7 receptors. Abbreviations: 6-OHDA: 6-hydroxydopamine; DMSO: dimethyl sulfoxide; DA: dopamine; EPM: elevated plus maze; MFB: medial forebrain bundlem; PFC: medial prefrontal cortex; NA: noradrenaline; PD: Pakinson's disease; PrL: prelimbic; 5-HT: serotonin; vHip: ventral hippocampus